Chinese search giant Baidu will begin manufacturing electric vehicles and has tapped China's largest privately-owned carmaker Geely to invest as a strategic partner.
The said move is the latest by a tech company to venture into the electric vehicle industry.
Baidu will form a new company that would use its artificial intelligence capabilities and mapping systems and Geely's electric vehicle modular platform.
The new car company, which will operate as an independent subsidiary, will focus on passenger vehicles.
Meanwhile, Geely said been trying to transform from a car manufacturer to "a tech company" focused on "intelligent, electric transport."
Reports of a team-up with Baidu pushed shares in Geely, which owns Volvo, by nearly 20 percent on Friday, which is its best since November 2008.


SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
U.S. Stock Futures Rise as Markets Brace for Jobs and Inflation Data
Trump Lifts 25% Tariff on Indian Goods in Strategic U.S.–India Trade and Energy Deal
Dollar Near Two-Week High as Stock Rout, AI Concerns and Global Events Drive Market Volatility
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Bank of Japan Signals Readiness for Near-Term Rate Hike as Inflation Nears Target
Indian Refiners Scale Back Russian Oil Imports as U.S.-India Trade Deal Advances
Yen Slides as Japan Election Boosts Fiscal Stimulus Expectations
Japan Economy Poised for Q4 2025 Growth as Investment and Consumption Hold Firm
Dow Hits 50,000 as U.S. Stocks Stage Strong Rebound Amid AI Volatility
DBS Expects Slight Dip in 2026 Net Profit After Q4 Earnings Miss on Lower Interest Margins
Trump’s Inflation Claims Clash With Voters’ Cost-of-Living Reality
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Asian Markets Surge as Japan Election, Fed Rate Cut Bets, and Tech Rally Lift Global Sentiment
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Japanese Pharmaceutical Stocks Slide as TrumpRx.gov Launch Sparks Market Concerns 



